HC upholds its earlier order on asthma drug Indamet against Glenmark Pharma

Sun Pharma Laboratories, a wholly-owned subsidiary of Sun Pharmaceutical Industries, and Glenmark are contesting over their right to use drug names “Istamet” and “Indamet”, respectively, which Sun Pharma finds to be deceptively similar and confusing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/E5wHpdq
via IFTTT